Cargando…

The ARID1A, p53 and ß-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium

AIM: The objective of this study was to evaluate the prognostic value of ARID1A, p53, p21, p16 and ß-Catenin in endometrioid and clear cell ovarian and endometrial carcinomas. MATERIALS AND METHODS: 97 tumors were available for analysis of ARID1A, p53, p21, p16 and ß-Catenin with the techniques of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heckl, Marlene, Schmoeckel, Elisa, Hertlein, Linda, Rottmann, Miriam, Jeschke, Udo, Mayr, Doris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815611/ https://www.ncbi.nlm.nih.gov/pubmed/29451900 http://dx.doi.org/10.1371/journal.pone.0192881

Ejemplares similares

MSX1-expression during the different phases in healthy human endometrium
por: Eppich, Simon, et al.
Publicado: (2023)

Inactivation of Arid1a in the endometrium is associated with endometrioid tumorigenesis through transcriptional reprogramming
por: Suryo Rahmanto, Yohan, et al.
Publicado: (2020)

The Association between Primary Endometrioid Carcinoma of the Ovary and Synchronous Malignancy of the Endometrium
por: van Niekerk, Catharina C., et al.
Publicado: (2010)

Endometrioid Carcinomas of the Ovaries and Endometrium Involving Endocervical Polyps: Comprehensive Clinicopathological Analyses
por: Sohn, Jihee, et al.
Publicado: (2022)

EZH2 inhibition in ARID1A mutated clear cell and endometrioid ovarian and endometrioid endometrial cancers
por: Alldredge, Jill K., et al.
Publicado: (2017)

Clinicopathological correlations of endometrioid and clear cell carcinomas in the uterus and ovary
por: Mori, Hidemi, et al.
Publicado: (2023)

Increased proliferation in atypical hyperplasia/endometrioid intraepithelial neoplasia of the endometrium with concurrent inactivation of ARID1A and PTEN tumour suppressors
por: Ayhan, Ayse, et al.
Publicado: (2015)

Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium
por: Lawrenson, Kate, et al.
Publicado: (2015)

H3K4me3 Is a Potential Mediator for Antiproliferative Effects of Calcitriol (1α,25(OH)2D3) in Ovarian Cancer Biology
por: Han, Nan, et al.
Publicado: (2020)

Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary
por: Morioka, Sachiko, et al.
Publicado: (2019)

Is lymphadenectomy a prognostic marker in endometrioid adenocarcinoma of the human endometrium?
por: Bassarak, Nina, et al.
Publicado: (2010)

Endometriosis in clear cell and endometrioid carcinoma ovary: its impact on clinicopathological characteristics and survival outcomes
por: Kundur, Mythili, et al.
Publicado: (2023)

PD-L1 expression and survival in p16-negative and -positive squamous cell carcinomas of the vulva
por: Czogalla, Bastian, et al.
Publicado: (2020)

The G-Protein-Coupled Estrogen Receptor (GPER) Regulates Trimethylation of Histone H3 at Lysine 4 and Represses Migration and Proliferation of Ovarian Cancer Cells In Vitro
por: Han, Nan, et al.
Publicado: (2021)

Sertoliform endometrioid carcinoma of the right ovary
por: Alali, Mohammad, et al.
Publicado: (2023)

Androgen signalling in the ovaries and endometrium
por: Lissaman, Abbey C, et al.
Publicado: (2023)

Sertoliform Endometrioid Tumor of Ovary Presenting as Torsion
por: Pai, Prathiksha, et al.
Publicado: (2016)

Role of serum microRNAs as biomarkers for endometriosis, endometrioid carcinoma of ovary & endometrioid endometrial cancer
por: Kumari, Priti, et al.
Publicado: (2022)

Overall Survival of Ovarian Cancer Patients Is Determined by Expression of Galectins-8 and -9
por: Schulz, Heiko, et al.
Publicado: (2018)

Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients †
por: Schulz, Heiko, et al.
Publicado: (2017)

Polypoid nodular histiocytic hyperplasia associated with endometrioid adenocarcinoma of the endometrium: report of a case
por: Akhter, Shabnam, et al.
Publicado: (2014)

Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium
por: Pradhan, M., et al.
Publicado: (2012)

Endometrioid adenocarcinoma concurrent with a blue nevus of the endometrium and uterine cervix: A case report
por: ISHIDA, MITSUAKI, et al.
Publicado: (2013)

Peritoneal Fluid Cytology of Disseminated Large Cell Neuroendocrine Carcinoma Combined with Endometrioid Adenocarcinoma of the Endometrium
por: Lee, Yong-Moon, et al.
Publicado: (2019)

Utility of AMACR immunohistochemical staining in differentiating Arias-Stella reaction from clear cell carcinoma of ovary and endometrium
por: Nili, Fatemeh, et al.
Publicado: (2023)

Sertoliform Endometrioid Carcinoma of Ovary Presenting as Abdominal Wall Abscess
por: Subbaiah, Murali, et al.
Publicado: (2018)

MSX1—A Potential Marker for Uterus-Preserving Therapy of Endometrial Carcinomas
por: Eppich, Simon, et al.
Publicado: (2020)

Microscopic lesions of fallopian tubes in endometrioid carcinoma of the endometrium: How effective are the macroscopic tubal sampling techniques?
por: Kulac, Ibrahim, et al.
Publicado: (2013)

HPV11 Positive Endometrioid Carcinoma of the Endometrium with Signet-Ring Cells: Diagnostic Criteria and Review of the Literature
por: Pusiol, Teresa
Publicado: (2014)

Potential Interplay of the Gatipotuzumab Epitope TA-MUC1 and Estrogen Receptors in Ovarian Cancer
por: Heublein, Sabine, et al.
Publicado: (2019)

Atypical proliferative endometrioid tumor of ovary: Report of a rare case
por: Jetley, S, et al.
Publicado: (2016)

Risk of synchronous endometrial disorders in women with endometrioid borderline tumors of the ovary
por: Jia, Shuang-zheng, et al.
Publicado: (2018)

Gynaecological cancers and leptin: A focus on the endometrium and ovary
por: Ray, A, et al.
Publicado: (2018)

Synchronous carcinomas of endometrium and ovary: A pragmatic approach
por: Blake Gilks, C., et al.
Publicado: (2018)

Interaction of ERα and NRF2 Impacts Survival in Ovarian Cancer Patients
por: Czogalla, Bastian, et al.
Publicado: (2018)

Extracapsular Lymph Node Involvement in Ovarian Carcinoma
por: Heublein, Sabine, et al.
Publicado: (2019)

A pragmatic approach to carcinomas concurrently involving the endometrium and ovary
por: Murali, Rajmohan, et al.
Publicado: (2018)

Expression of H3K4me3 and H3K9ac in breast cancer
por: Berger, Luisa, et al.
Publicado: (2020)

Sirtuin1 expression and survival in endometrial and clear-cell uterine cancer
por: Beyer, Susanne, et al.
Publicado: (2020)

p53 aberrations in low grade endometrioid carcinoma of the endometrium with nodal metastases: possible insights on pathogenesis discerned from immunohistochemistry
por: Fadare, Oluwole, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ata5o7ll1qr7763og2bl01jdfs